Eureka Forbes Ltd News
Eureka Forbes targets ₹5,400-5,600 crore revenue, triple Ebitda by FY30
Eureka Forbes Ltd, which operates in the health and hygiene products segment, aims to double its revenue to Rs 5,400-5,600 crore and triple EBITDA to Rs 800-850 crore by FY30, from the base levels of FY25, the company said in its latest annual report. The company is banking on innovation, deeper market penetration and stronger omnichannel capabilities to accelerate growth from FY27 onwards, said Eureka Forbes. Eureka Forbes is primarily owned by the US private equity firm Advent International, which acquired a controlling stake in it from the Shapoorji Pallonji Group in 2022. "We expect this growth trajectory to build progressively over the coming years, with a meaningful acceleration from FY27 onwards as the strong foundations we have built translate into faster, broad-based growth. This acceleration will be driven by continued innovation, deeper market penetration across our core and emerging categories, stronger omnichannel execution, and sustained improvements in operating ...
 "Eureka Forbes targets ₹5,400-5,600 crore revenue, triple Ebitda by FY30")
UBS sees 45% upside in Eureka Forbes; says market under-appreciating stock
UBS has initiated coverage on Eureka Forbes with a 'Buy' rating and 12-month target price of ₹640, implying 44.6 per cent upside from current levels
 "UBS sees 45% upside in Eureka Forbes; says market under-appreciating stock")